1. How might Segway, Inc. further develop the market for Segway technology? Hint: What types of marketing strategies are associated with sales growth?

Amid heavy media coverage and much speculation, “Ginger”
made its debut on ABC’s Good Morning America on December 3, 2001. It thrilled some and disappointed others, but the technology was breathtaking to all.
Now known as the Segway Human Transporter (HT), Ginger was the brainchild of inventor and entrepreneur Dean Kamen, who is best known for his inventions in the medical field. While in college, Kamen invented the first wearable drug-infusion pump. In the following years, he invented the first portable insulin pump, the first portable dialysis machine, and an array of heart stents. This string of successes established Kamen’s reputation and turned DEKA Research and Development Corp., the R&D lab he founded, into a premier company for medical-device design.
The inspiration for Ginger occurred during the development of the IBOT wheelchair at DEKA. Developed for and funded by Johnson & Johnson, the IBOT wheelchair is a gyrostabilized, microprocessor-controlled wheelchair that gives disabled people the same kind of mobility the rest of us take for granted. Officially called the Independence IBOT mobility system, this six-wheel machine can go up and down curbs, cruise effortlessly through sand or gravel, climb stairs, and rise up on its wheels to lift its occupant to eye level while maintaining balance and maneuverability with such stability that it can’t be knocked over. The IBOT wheelchair has been likened to a sophisticated robot.